Soleno Therapeutics Inc (SLNO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 70,106 | 87,928 | 169,681 | 14,602 | 21,304 |
| Marketable Securities | 235,366 | 203,509 | N/A | N/A | N/A |
| Receivables | 28,208 | N/A | N/A | N/A | N/A |
| Inventories | 15,024 | N/A | N/A | N/A | N/A |
| TOTAL | $355,814 | $293,889 | $171,358 | $15,647 | $22,422 |
| Non-Current Assets | |||||
| PPE Net | 185 | 186 | 12 | 26 | 33 |
| Investments And Advances | 200,616 | 27,211 | 0 | 0 | 0 |
| Intangibles | 4,861 | 6,805 | 8,749 | 10,693 | 12,637 |
| Other Non-Current Assets | 2,354 | 2,881 | 572 | 131 | 461 |
| TOTAL | $208,016 | $37,083 | $9,333 | $10,850 | $13,131 |
| Total Assets | $563,830 | $330,972 | $180,691 | $26,497 | $35,553 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 12,435 | 8,882 | 3,149 | 1,777 | 3,254 |
| Accrued Expenses | 9,677 | 4,776 | 6,528 | 4,897 | 4,148 |
| Other current liabilities | 38,525 | 4,563 | 1,555 | 484 | 323 |
| TOTAL | $61,363 | $18,747 | $11,505 | $7,313 | $8,007 |
| Non-Current Liabilities | |||||
| Long Term Debt | 49,863 | 49,828 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 2,489 | 17,284 | 11,679 | 8,836 | 9,753 |
| TOTAL | $52,352 | $67,112 | $11,679 | $8,836 | $9,753 |
| Total Liabilities | $113,715 | $85,859 | $23,184 | $16,149 | $17,760 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 51,624 | 45,857 | 32,461 | 8,169 | 5,342 |
| Common Shares | 52 | 46 | 32 | 8 | 80 |
| Retained earnings | -431,370 | -452,260 | -276,410 | -237,422 | -213,355 |
| Other shareholders' equity | 415 | 361 | 0 | 0 | 0 |
| TOTAL | $450,115 | $245,113 | $157,507 | $10,348 | $17,793 |
| Total Liabilities And Equity | $563,830 | $330,972 | $180,691 | $26,497 | $35,553 |